Literature DB >> 10146141

Guideline for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention.

.   

Abstract

Pneumonia is the second most common nosocomial infection in the United States and is associated with substantial morbidity and mortality. Most patients with nosocomial pneumonia are those with extremes of age, severe underlying disease, immunosuppression, depressed sensorium, and cardiopulmonary disease, and those who have had thoracoabdominal surgery. Although patients with mechanically assisted ventilation do not comprise a major proportion of patients with nosocomial pneumonia, they have the highest risk of developing the infection. Most bacterial nosocomial pneumonias occur by aspiration of bacteria colonizing the oropharynx or upper gastrointestinal tract of the patient. Intubation and mechanical ventilation greatly increase the risk of nosocomial bacterial pneumonia because they alter first-line patient defenses. Pneumonias due to Legionella spp., Aspergillus spp., and influenza virus are often caused by inhalation of contaminated aerosols. Respiratory syncytial virus (RSV) infection usually follows viral inoculation of the conjunctivae or nasal mucosa by contaminated hands. Traditional preventive measures for nosocomial pneumonia include decreasing aspiration by the patient, preventing cross-contamination or colonization via hands of personnel, appropriate disinfection or sterilization or respiratory therapy devices, use of available vaccines to protect against particular infections, and education of hospital staff and patients. New measures under investigation involve reducing oropharyngeal and gastric colonization by pathogenic microorganisms.

Entities:  

Mesh:

Year:  1994        PMID: 10146141

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  11 in total

1.  Staged abdominal repair for treatment of moderate to severe secondary peritonitis.

Authors:  Fatih Agalar; Erol Eroglu; Mahmut Bulbul; Canan Agalar; Omar Ridvan Tarhan; Mustafa Sari
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

2.  The microbial colonization profile of respiratory devices and the significance of the role of disinfection: a blinded study.

Authors:  Savita Jadhav; Tushar Sahasrabudhe; Vipul Kalley; Nageswari Gandham
Journal:  J Clin Diagn Res       Date:  2013-05-11

3.  Efficient management and maintenance of ultrasonic nebulizers to prevent microbial contamination.

Authors:  Yoko Ida; Hiroaki Ohnishi; Kouji Araki; Ryoichi Saito; Shin Kawai; Takashi Watanabe
Journal:  World J Methodol       Date:  2016-03-26

4.  Mechanical ventilation weaning and extubation after spinal cord injury: a Western Trauma Association multicenter study.

Authors:  Lucy Z Kornblith; Matthew E Kutcher; Rachael A Callcut; Brittney J Redick; Charles K Hu; Thomas H Cogbill; Christopher C Baker; Mark L Shapiro; Clay C Burlew; Krista L Kaups; Marc A DeMoya; James M Haan; Christopher H Koontz; Samuel J Zolin; Stephanie D Gordy; David V Shatz; Doug B Paul; Mitchell J Cohen
Journal:  J Trauma Acute Care Surg       Date:  2013-12       Impact factor: 3.313

5.  Impact of positive legionella urinary antigen test on patient management and improvement of antibiotic use.

Authors:  J Garbino; J-E Bornand; I Uçkay; S Fonseca; H Sax
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

6.  Humidifiers for oxygen therapy: what risk for reusable and disposable devices?

Authors:  V La Fauci; G B Costa; A Facciolà; A Conti; R Riso; R Squeri
Journal:  J Prev Med Hyg       Date:  2017-06

Review 7.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

8.  A continuous quality-improvement program reduces nosocomial infection rates in the ICU.

Authors:  Benoit Misset; Jean-François Timsit; Marie-Françoise Dumay; Maité Garrouste; Annie Chalfine; Isabelle Flouriot; Fred Goldstein; Jean Carlet
Journal:  Intensive Care Med       Date:  2003-12-12       Impact factor: 17.440

9.  Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa.

Authors:  Marc J Schultz; Sylvia Knapp; Sandrine Florquin; Jennie Pater; Kiyoshi Takeda; Shizuo Akira; Tom van der Poll
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery.

Authors:  Wolfgang Oczenski; Herbert Krenn; Ruth Jilch; Herbert Watzka; Ferdinand Waldenberger; Ursula Köller; Sylvia Schwarz; Robert D Fitzgerald
Journal:  Intensive Care Med       Date:  2003-06-12       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.